Quetiapine Impurity 21 | CAS 2108892-53-9 - Request Quote
Quetiapine Impurity 21
| SZ CAT No: | SZ-Q001074 |
| CAS No | 2108892-53-9 |
| Mol.F. | C21H25N3O2S |
| Mol.Wt. | 383.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Quetiapine Impurity 21 is chemically 11-(2-(2-(Piperazin-1-yl)ethoxy)ethoxy)dibenzo[b,f][1,4]thiazepine. Quetiapine Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Quetiapine Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Quetiapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2108892-53-9
Purchase 2108892-53-9
Order 2108892-53-9
Enquire 2108892-53-9
price of 2108892-53-9
2108892-53-9 Supplier
2108892-53-9 Manufacturer
2108892-53-9 Exporter
buy high quality Quetiapine Impurity 21
Purchase Quetiapine Impurity 21
Quetiapine Impurity 21 suppliers
Quetiapine Impurity 21 manufacturers
Quetiapine Impurity 21 price
Order Quetiapine Impurity 21
Enquire Quetiapine Impurity 21
Quetiapine Impurity 21 cost
Quetiapine Impurity 21 Supplier
Quetiapine Impurity 21 Distributor
Quetiapine Impurity 21 for Method Validation
Quetiapine Reference Standard
Quetiapine Impurity 21 for ANDA Filing
Quetiapine Impurity 21 for Forced Degradation Studies
Quetiapine Impurity 21 Identification Standards
Quetiapine Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.